Clinical Trial Update: A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating GC4419 for radiation-induced oral mucositis in head/neck cancer patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Radiation-induced Oral Mucositis

Drugs mentioned

• GC4419

Snippet

Sponsor: Galera Therapeutics, Inc. | Conditions: Radiation Induced Oral Mucositis | Phase 2 | Status: COMPLETED | Results posted: 2021-09-20